Fagron Reports 20% Revenue Growth For Q3; Completes Acquisition Of Injeplast

Fagron NV (FAGR.BR), a pharmaceutical company, on Thursday released financial results for the third quarter, noting a significant surge in revenue as certain segments outperformed previous year sales.
Read the full report on Rttnews
Story file
How this page works. The Headline Update lists this report from Rttnews with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.




